Skip to main content

Advertisement

SpringerLink
Log in

MicroRNA-144 inhibits the proliferation, apoptosis, invasion, and migration of osteosarcoma cell line F5M2

  • Research Article
  • Published:
Tumor Biology

Abstract

This study is aimed to investigate the role of microRNA-144 (miR-144) in osteosarcoma cell line F5M2 proliferation, apoptosis, invasion, and metastasis. Between 2007 and 2014, 66 cases of osteosarcoma samples in the corresponding adjacent normal tissue samples were selected from surgical resection or biopsy in the Department of Orthopedics, Shengjing Hospital, China Medical University. MiR-144 levels and Ezrin messenger RNA (mRNA) levels in osteosarcoma and the adjacent bone tissues were detected, and clinical and pathological features were analyzed. Exogenous miR-144 was transfected into human osteosarcoma cell lines at two different concentrations (low and high), and the expression levels of miR-144 and Ezrin protein between highly metastatic osteosarcoma cells and lowly metastatic osteosarcoma cells were compared. Real-time polymerase chain reaction (RT-PCR) and Western blot were used for detecting the expression levels of miR-144 or Ezrin protein, respectively. Cell proliferation was measured by methylthiazol tetrazolium (MTT) assay. Cell invasion and migration was evaluated by Transwell assays. Finally, flow cytometry was employed to determine the cell apoptosis. MiR-144 expression in osteosarcoma tissue was significantly lower than that in the surrounding normal bone tissue (P < 0.001), while Ezrin mRNA expression in osteosarcoma tissue was significantly higher than that in the surrounding normal bone tissue (P < 0.001); correlation analysis showed a significant negative correlation between miR-144 and Ezrin mRNA levels (r = 0.982, P < 0.001). MiR-144 and Ezrin mRNA expressions were significantly related with cell metastasis (P < 0.05) but were not related with other clinical factors such as gender, age, tumor location, tumor size, Enneking staging, and Dahlin’s histological classification. The results of RT-PCR showed that the expression level of miR-144 in osteosarcoma cells increased after transfected with exogenous miR-144 mimics, and this increase positively correlated with the transfection concentration of miR-144 mimics. Furthermore, Western blotting revealed a significant and dose-dependent decrease in Ezrin protein levels in F5M2 cells transfected with miR-144. MTT and Transwell assays showed that the invasion and metastasis of F5M2 cells was significantly decreased following exogenous overexpression of miR-144. Our study supports the view that the miR-144 may regulate Ezrin protein expression by inhibiting the invasion and metastasis of osteosarcoma cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Yuan D, Liu B, Liu K, Zhu G, Dai Z, Xie Y. Overexpression of fibroblast activation protein and its clinical implications in patients with osteosarcoma. J Surg Oncol. 2013;108(3):157–62.

    Article  CAS  PubMed  Google Scholar 

  2. Sabatier R, Bouvier C, de Pinieux G, Sarran A, Brenot-Rossi I, Pedeutour F, et al. Low-grade extraskeletal osteosarcoma of the chest wall: case report and review of literature. BMC Cancer. 2010;10:645.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Wang Z, Cai H, Lin L, Tang M, Cai H. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma. Pediatr Blood Cancer. 2014;61(2):206–10.

    Article  PubMed  Google Scholar 

  4. Mu Y, Zhang H, Che L, Li K. Clinical significance of microRNA-183/Ezrin axis in judging the prognosis of patients with osteosarcoma. Med Oncol. 2014;31(2):821.

    Article  PubMed  Google Scholar 

  5. Jiang C, Chen H, Shao L, Dong Y. GRM4 gene polymorphism is associated with susceptibility and prognosis of osteosarcoma in a Chinese Han population. Med Oncol. 2014;31(7):50.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Ottaviani G, Jaffe N. The etiology of osteosarcoma. Cancer Treat Res. 2009;152:15–32.

    Article  PubMed  Google Scholar 

  7. Kourti M, Sidi V, Papakonstantinou E. Osteosarcoma in an adolescent previously treated for Hodgkin’s disease. Hippokratia. 2014;18(1):96.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res. 2009;152:3–13.

    Article  PubMed  Google Scholar 

  9. Duan Z, Choy E, Harmon D, Liu X, Susa M, Mankin H, et al. MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. Mol Cancer Ther. 2011;10(8):1337–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Kobayashi E, Hornicek FJ, Duan Z. MicroRNA involvement in osteosarcoma. Sarcoma. 2012;2012:359739.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Fujii T, Yajima R, Hirakata T, Miyamoto T, Fujisawa T, Tsutsumi S, et al. Impact of the prognostic value of vascular invasion, but not lymphatic invasion, of the primary tumor in patients with breast cancer. Anticancer Res. 2014;34(3):1255–9.

    PubMed  Google Scholar 

  12. Toledo SR, Oliveira ID, Okamoto OK, Zago MA, de Seixas Alves MT, Filho RJ, et al. Bone deposition, bone resorption, and osteosarcoma. J Orthop Res: Off Publ Orthop Res Soc. 2010;28(9):1142–8.

    Article  Google Scholar 

  13. Lee JS, DuBois SG, Boscardin WJ, Wustrack RL, Goldsby RE. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma. Cancer. 2014;120(24):3987–93.

    Article  PubMed  Google Scholar 

  14. An J, Choi KP, Wells CA, Chen YP. Identifying co-regulating microRNA groups. J Bioinforma Comput Biol. 2010;8(1):99–115.

    Article  CAS  Google Scholar 

  15. He C, Xiong J, Xu X, Lu W, Liu L, Xiao D, et al. Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples. Biochem Biophys Res Commun. 2009;388(1):35–40.

    Article  CAS  PubMed  Google Scholar 

  16. Du TT, Fu YF, Dong M, Wang L, Fan HB, Chen Y, et al. Experimental validation and complexity of miRNA-mRNA target interaction during zebrafish primitive erythropoiesis. Biochem Biophys Res Commun. 2009;381(4):688–93.

    Article  CAS  PubMed  Google Scholar 

  17. Creighton CJ, Fountain MD, Yu Z, Nagaraja AK, Zhu H, Khan M, et al. Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. Cancer Res. 2010;70(5):1906–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Drusco A, Nuovo GJ, Zanesi N, Di Leva G, Pichiorri F, Volinia S, et al. MicroRNA profiles discriminate among colon cancer metastasis. PLoS One. 2014;9(6):e96670.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Guan H, Liang W, Xie Z, Li H, Liu J, Liu L, et al. Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2. Endocrine. 2014 Jun;27.

  20. Zha W, Cao L, Shen Y, Huang M. Roles of Mir-144-ZFX pathway in growth regulation of non-small-cell lung cancer. PLoS One. 2013;8(9):e74175.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Kalimutho M, Del Vecchio BG, Di Cecilia S, Sileri P, Cretella M, Pallone F, et al. Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer. J Gastroenterol. 2011;46(12):1391–402.

    Article  CAS  PubMed  Google Scholar 

  22. Liu Y, Wang X, Jiang J, Cao Z, Yang B, Cheng X. Modulation of T cell cytokine production by miR-144* with elevated expression in patients with pulmonary tuberculosis. Mol Immunol. 2011;48(9–10):1084–90.

    Article  CAS  PubMed  Google Scholar 

  23. Andersson G, Wennersten C, Gaber A, Boman K, Nodin B, Uhlen M, et al. Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts. BMC Urol. 2014;14:36.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Athanasopoulou A, Aroukatos P, Nakas D, Repanti M, Papadaki H, Bravou V. Decreased ezrin and paxillin expression in human urothelial bladder tumors correlate with tumor progression. Urol Oncol. 2013;31(6):836–42.

    Article  CAS  PubMed  Google Scholar 

  25. Ren L, Khanna C. Role of ezrin in osteosarcoma metastasis. Adv Exp Med Biol. 2014;804:181–201.

    Article  CAS  PubMed  Google Scholar 

  26. Zhao M, Huang J, Gui K, Xiong M, Cai G, Xu J, et al. The downregulation of mir-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression. Int J Mol Med. 2014;34(6):1565–72.

    CAS  PubMed  Google Scholar 

  27. Enneking WF. A system of staging musculoskeletal neoplasms. Clin Orthop Relat Res. 1986;204:9–24.

    Google Scholar 

  28. Zhang C, Yao C, Li H, Wang G, He X. Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma. Int J Clin Exp Pathol. 2014;7(7):4194–203.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Han K, Zhao T, Chen X, Bian N, Yang T, Ma Q, et al. MicroRNA-194 suppresses osteosarcoma cell proliferation and metastasis in vitro and in vivo by targeting CDH2 and IGF1R. Int J Oncol. 2014;45(4):1437–49.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Zhou X, Wei M, Wang W. MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1. Biochem Biophys Res Commun. 2013;437(4):653–8.

    Article  CAS  PubMed  Google Scholar 

  31. Yan K, Gao J, Yang T, Ma Q, Qiu X, Fan Q, et al. MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo. PLoS One. 2012;7(3):e33778.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Botter SM, Neri D, Fuchs B. Recent advances in osteosarcoma. Curr Opin Pharmacol. 2014;16:15–23.

    Article  CAS  PubMed  Google Scholar 

  33. Won KY, Kim YW, Kim HS, Lee SK, Jung WW, Park YK. MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma. Hum Pathol. 2013;44(8):1648–55.

    Article  CAS  PubMed  Google Scholar 

  34. Song B, Wang Y, Titmus MA, Botchkina G, Formentini A, Kornmann M, et al. Molecular mechanism of chemoresistance by mir-215 in osteosarcoma and colon cancer cells. Mol Cancer. 2010;9:96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Ziyan W, Shuhua Y, Xiufang W, Xiaoyun L. MicroRNA-21 is involved in osteosarcoma cell invasion and migration. Med Oncol. 2011;28(4):1469–74.

    Article  PubMed  Google Scholar 

  36. Zhao H, Guo M, Zhao G, Ma Q, Ma B, Qiu X, et al. MiR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells. Int J Mol Med. 2012;30(5):1013–20.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Zhang J, Zuo J, Lei M, Wu S, Zang X, Zhang C. Ezrin promotes invasion and migration of the MG63 osteosarcoma cell. Chin Med J. 2014;127(10):1954–9.

    CAS  PubMed  Google Scholar 

  38. Zhu J, Feng Y, Ke Z, Yang Z, Zhou J, Huang X, et al. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin. Am J Pathol. 2012;180(6):2440–51.

    Article  CAS  PubMed  Google Scholar 

  39. Bulut G, Hong SH, Chen K, Beauchamp EM, Rahim S, Kosturko GW, et al. Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells. Oncogene. 2012;31(3):269–81.

    Article  CAS  PubMed  Google Scholar 

  40. Rodriguez-Pinilla SM, Sanchez ME, Rodriguez J, Garcia JF, Sanchez-Espiridion B, Lamana LF, et al. Loss of TCR-beta F1 and/or EZRIN expression is associated with unfavorable prognosis in nodal peripheral T-cell lymphomas. Blood Cancer J. 2013;3:e111.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Wang JW, Peng SY, Li JT, Wang Y, Zhang ZP, Cheng Y, et al. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. Cancer Lett. 2009;281(1):71–81.

    Article  CAS  PubMed  Google Scholar 

  42. Ferrari S, Zanella L, Alberghini M, Palmerini E, Staals E, Bacchini P. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma. Pediatr Blood Cancer. 2008;50(4):752–6.

    Article  PubMed  Google Scholar 

  43. Lam EK, Wang X, Shin VY, Zhang S, Morrison H, Sun J, et al. A microRNA contribution to aberrant Ras activation in gastric cancer. Am J Transl Res. 2011;3(2):209–18.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We would like to acknowledge the reviewers for their helpful comments on this paper.

Conflicts of interest

None

Authors’ contributions

SQ Cui designed, conceived, and supervised the study; performed the examination and the analysis; interpreted the results; and revised the paper. H Wang conceived and supervised the study, performed the statistical analysis, interpreted the results, and drafted the paper. All authors read and approved the final paper.

Author information

Authors and Affiliations

  1. Department of Orthopedics, Shengjing Hospital Affiliated to China Medical University, Shenyang, 110004, China

    Shao-Qian Cui

  2. Department of Orthopedics, Shengjing Hospital Affiliated to China Medical University, No. 36 San Hao Street, Heping District, Shenyang, 110004, Liaoning Province, China

    Huan Wang

Authors
  1. Shao-Qian Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Huan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Huan Wang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cui, SQ., Wang, H. MicroRNA-144 inhibits the proliferation, apoptosis, invasion, and migration of osteosarcoma cell line F5M2. Tumor Biol. 36, 6949–6958 (2015). https://doi.org/10.1007/s13277-015-3396-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-3396-0

Keywords

Search

Navigation